CL
| Investor | Type | Est. change | Change | Δ Own | Date | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Point72 Asset Management, L.P.
· Added
Change
+1.5M
Δ Own
+83.7%
Date
Q1 2026
|
Point72 Asset Management, L.P. | Added· Q1 2026 | – | +1.5M | +83.7% | Q1 2026 | |||||
|
Wellington Management Group LLP
· Added
Change
+481K
Δ Own
+6.0%
Date
Q1 2026
|
Wellington Management Group LLP | Added· Q1 2026 | – | +481K | +6.0% | Q1 2026 | |||||
|
Ikarian Capital, LLC
· New
Change
+461K
Date
Q1 2026
|
Ikarian Capital, LLC | New· Q1 2026 | – | +461K | – | Q1 2026 | |||||
|
Dimensional
· Added
Change
+408K
Date
Q1 2026
|
Dimensional | Added· Q1 2026 | – | +408K | – | Q1 2026 | |||||
|
Eversept Partners, LP
· Added
Change
+353K
Date
Q1 2026
|
Eversept Partners, LP | Added· Q1 2026 | – | +353K | – | Q1 2026 | |||||
|
Kennedy Capital Management LLC
· New
Change
+352K
Date
Q1 2026
|
Kennedy Capital Management LLC | New· Q1 2026 | – | +352K | – | Q1 2026 | |||||
|
Rosalind Advisors, Inc.
· New
Change
+330K
Date
Q1 2026
|
Rosalind Advisors, Inc. | New· Q1 2026 | – | +330K | – | Q1 2026 | |||||
|
Foresite Capital Management VI LLC
· New
Change
+316K
Date
Q1 2026
|
Foresite Capital Management VI LLC | New· Q1 2026 | – | +316K | – | Q1 2026 | |||||
|
Palo Alto Investors LP
· New
Change
+296K
Date
Q1 2026
|
Palo Alto Investors LP | New· Q1 2026 | – | +296K | – | Q1 2026 | |||||
|
Bank of America Corp
· Added
Change
+294K
Date
Q1 2026
|
Bank of America Corp | Added· Q1 2026 | – | +294K | – | Q1 2026 | |||||
|
Candriam S.c.a.
· New
Change
+279K
Date
Q1 2026
|
Candriam S.c.a. | New· Q1 2026 | – | +279K | – | Q1 2026 | |||||
|
Stempoint Capital LP
· New
Change
+254K
Date
Q1 2026
|
Stempoint Capital LP | New· Q1 2026 | – | +254K | – | Q1 2026 | |||||
|
Citigroup Inc
· Added
Change
+202K
Date
Q1 2026
|
Citigroup Inc | Added· Q1 2026 | – | +202K | – | Q1 2026 | |||||
|
Summittx Capital, L.P.
· Added
Change
+193K
Date
Q1 2026
|
Summittx Capital, L.P. | Added· Q1 2026 | – | +193K | – | Q1 2026 | |||||
|
Pfm Health Sciences, LP
· Added
Change
+192K
Date
Q1 2026
|
Pfm Health Sciences, LP | Added· Q1 2026 | – | +192K | – | Q1 2026 | |||||
| Insider | Title | Type | Price | Qty | Value | Owned | ΔOwn | Trade date | Filed date | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Lawver Teri L.
· Officer
Grant (A)
90K
|
Lawver Teri L. | Officer | Grant (A) | – | 90K | – | 90K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Jimenez Freddy A.
· Officer
Grant (A)
93K
|
Jimenez Freddy A. | Officer | Grant (A) | – | 93K | – | 93K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Young Diane C.
· Officer
Grant (A)
57K
|
Young Diane C. | Officer | Grant (A) | – | 57K | – | 57K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Heath-Chiozzi Margo
· Officer
Grant (A)
95K
|
Heath-Chiozzi Margo | Officer | Grant (A) | – | 95K | – | 95K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Martin Samuel Bates
· Officer
Grant (A)
93K
|
Martin Samuel Bates | Officer | Grant (A) | – | 93K | – | 93K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Cavanaugh Sarah
· Officer
Grant (A)
95K
|
Cavanaugh Sarah | Officer | Grant (A) | – | 95K | – | 95K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Crowley Elizabeth
· Officer
Grant (A)
100K
|
Crowley Elizabeth | Officer | Grant (A) | – | 100K | – | 100K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Pepin Ronald
· Officer
Grant (A)
20K
|
Pepin Ronald | Officer | Grant (A) | – | 20K | – | 20K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Keler Tibor
· Officer
Grant (A)
115K
|
Keler Tibor | Officer | Grant (A) | – | 115K | – | 115K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Marucci Anthony S.
· Director
Grant (A)
375K
|
Marucci Anthony S. | Director | Grant (A) | – | 375K | – | 375K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Torres Denice
· Director
Grant (A)
26K
|
Torres Denice | Director | Grant (A) | – | 26K | – | 26K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Jain Rita
· Director
Grant (A)
26K
|
Jain Rita | Director | Grant (A) | – | 26K | – | 26K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Neil Garry Arthur
· Director
Grant (A)
26K
|
Neil Garry Arthur | Director | Grant (A) | – | 26K | – | 26K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Cohen Cheryl
· Director
Grant (A)
26K
|
Cohen Cheryl | Director | Grant (A) | – | 26K | – | 26K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
|
Brownlie Keith L.
· Director
Grant (A)
26K
|
Brownlie Keith L. | Director | Grant (A) | – | 26K | – | 26K | – | Jun 25, 2026 | Jun 29, 2026 | |||||||||
193 reporting institutions disclosed CLDX position changes in the Q1 2026 snapshot.
For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.
An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.
Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.
Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.
A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.